Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 46 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
MEDICAL AND PHARMACEUTICAL CONSULTANCY AND APPLICATIONS from Aalter, company number BE0475207552, closed financial year 2025 with a result of € -118,502 after tax. For that financial year MEDICAL AND PHARMACEUTICAL CONSULTANCY AND APPLICATIONS recorded a gross margin of € -49,225 and equity of € 2.1 million. Compared with financial year 2024, the result moved from € 70,617 to € -118,502. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on January 5, 2026.
€ 2.1 million
▼ 5% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -118,502
▼ still € 70,617 profit in 2024
Profit after tax over the fiscal year.
€ 164,145
▼ 1% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 2.1 million.
People and assets in 2025
0
Average over the fiscal year, from the social balance sheet.
€ 1,976
▼ 9% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 6,701
▼ 10% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 1,000
▼ 97% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 165,616 | € 133,600 | € 159,751 | € -49,225 | ▼ € 208,976 |
| Profit after taxes | € 51,337 | € 36,482 | € 70,617 | € -118,502 | ▼ € 189,119 |
| Equity | € 2,091,329 | € 2,127,811 | € 2,198,428 | € 2,079,926 | ▼ 5% |
| Total debts | € 823,207 | € 429,725 | € 446,710 | € 408,678 | ▼ 9% |
| Cash | € 1,034,628 | € 627,783 | € 166,133 | € 164,145 | ▼ 1% |
| Land & buildings | € 1,078,322 | € 1,006,293 | € 938,943 | € 874,180 | ▼ 7% |
| Retained profit | € 2,072,729 | € 2,109,211 | € 2,179,828 | € 2,061,326 | ▼ 5% |
| Dividend | € 350,000 | € 0 | € 0 | € 0 | |
| Balance sheet total | € 2,914,537 | € 2,557,536 | € 2,645,138 | € 2,488,604 | ▼ 6% |
Key figures of MEDICAL AND PHARMACEUTICAL CONSULTANCY AND APPLICATIONS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.
What happened to MEDICAL AND PHARMACEUTICAL CONSULTANCY AND APPLICATIONS?
What happened at MEDICAL AND PHARMACEUTICAL CONSULTANCY AND APPLICATIONS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 118,502 (▼ € 189,119 vs 2024). Source: NBB ↗
- Rottey Erika became a director. NBB
- New establishment in Aalter. KBO
- New establishment in Gent. KBO
- New establishment in Assenede. KBO
- Start of the company according to the CBE. KBO
In short
From € 51,337 profit in 2022 to € 118,502 loss in 2025.
Paid € 72,110 in corporate taxes since 2022.
Best year ever: 2024, with € 70,617 profit.
Paid out € 350,000 in dividends to the owners in total.
A new publication or filing at MEDICAL AND PHARMACEUTICAL CONSULTANCY AND APPLICATIONS? We notify you, reason included.
Follow MEDICAL AND PHARMACEUTICAL CONSULTANCY AND APPLICATIONSDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind MEDICAL AND PHARMACEUTICAL CONSULTANCY AND APPLICATIONS is Rottey Erika.
Directors
According to the 2025 annual accounts
Rottey Erika
Director
since 2019
Establishments
Establishment units
Physical locations of this company
Urselseweg 182
9910 Aalter
Vrijestraat 28
9960 Assenede
Active since 1 August 2001
Coupure 505
9000 Gent
Active since 12 January 2017
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0475.207.552
- VAT number
- BE 0475.207.552
- Registered office
- Urselseweg 182, 9910 Aalter
- Names & denominations
- MEDICAL AND PHARMACEUTICAL CONSULTANCY AND APPLICATIONS · MPCA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 5 July 2001
- Peppol
- Active · Active since 23 Dec 2025
- Activities · NACE
Verhuur en exploitatie van eigen of geleased residentieel onroerend goed, exclusief sociale woningen
Hotels en dergelijke accommodatie